2727 Marijuana

In September 2026, 2727 Marijuana concentrated 73.59% of sales in Pre-Roll, where sales declined 8.75% year over year and 1.88% month over month, while the brand held rank 9 in Washington Pre-Roll. Offsetting that contraction, Flower expanded to 22.57% share with 42.85% year-over-year growth and an 11.89% month-over-month lift, while Vapor Pens, at 2.06% share, inched down 0.92% year over year but jumped 26.35% month over month. Concentrates remained small at 1.78% share yet surged 7.72% year over year and 72.45% month over month, and the brand’s average price rose 7.39% year over year to $11.61. The mix points to a portfolio tilting away from a contracting Pre-Roll core toward faster-moving Flower and nascent rebounds in Vapor Pens and Concentrates, implying reliance on rank 9 in Pre-Roll is giving way to a more diversified volume base.

The pattern implies the brand’s positioning is shifting from single-category scale to multi-category relevance: a 73.59% Pre-Roll dependency alongside a 1.88% month-over-month decline contrasts with Flower’s 11.89% month-over-month gain and 42.85% year-over-year expansion, indicating incremental growth is more likely to come from Flower. With Vapor Pens up 26.35% month over month and Concentrates up 72.45% month over month off small bases, the brand’s 7.39% year-over-year price increase suggests room to trade consumers across tiers rather than leaning solely on volume in rank 9 Pre-Roll. Net, September 2026 mix shifts imply the path to stabilizing the brand’s 18.00% year-over-year sales decline runs through continued Flower scaling and selective investment in the high-velocity but low-share formats to dilute exposure to Pre-Roll softness.